A Study of IMR-687 in Subjects With Sickle Cell Disease
Clinical trial NCT04474314 · TERMINATED
Trial details
- NCT number
- NCT04474314
- Sponsor
- Cardurion Pharmaceuticals, Inc.
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-08-13
- Primary completion
- 2022-03-02
- Enrollment
- 115
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.